Skip to main content

Remedy Plan Therapeutics

Gaithersburg, United States

Remedy Plan is a pre-clinical cancer therapeutics company developing first-in-class small molecule drugs that differentiate cancer cells.

$18.0M raised
May 2025
Venture - Series Unknown

Top Investors

Alexandria Venture InvestmentsSchooner Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Remedy Plan Therapeutics

How much funding has Remedy Plan Therapeutics raised?
Remedy Plan Therapeutics has raised $18.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2025.
Who are Remedy Plan Therapeutics's investors?
Remedy Plan Therapeutics's investors include Alexandria Venture Investments, Schooner Capital.
Where is Remedy Plan Therapeutics headquartered?
Remedy Plan Therapeutics is headquartered in Gaithersburg, United States.
What does Remedy Plan Therapeutics do?
Remedy Plan is a pre-clinical cancer therapeutics company developing first-in-class small molecule drugs that differentiate cancer cells.
What stage is Remedy Plan Therapeutics at?
Remedy Plan Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Remedy Plan Therapeutics — Funding & Investors." VCBacked, May 13, 2025, https://www.vcbacked.co/company/remedy-plan-therapeutics. Accessed July 1, 2026.
APA
VCBacked. (2025). Remedy Plan Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/remedy-plan-therapeutics
Wikipedia (cite web)
{{cite web |title=Remedy Plan Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/remedy-plan-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .